Gilead Sciences, a biopharmaceutical company in the US, on Wednesday, announced “positive data” in the clinical trial of remdesivir, an experimental antiviral drug, for the treatment of COVID-19. Remdesivir was
Tag "Gilead Sciences"
Advertisement
Advertisement
Advertisement
Advertisement
Top Stories
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Life and Living
Advertisement
Advertisement